Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-19

Clinical Trial Update: Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of co-administered moxidectin and albendazole for soil-transmitted helminth infections has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • Moxidectin (moxidectin)

Snippet

Sponsor: Jennifer Keiser | Conditions: Trichuriasis, Ascariasis | Phase 3 | Status: COMPLETED | Results posted: 2025-09-19